- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02208895
iSTAT Comparison Study, IRB3785
March 4, 2020 updated by: University of Oklahoma
Correlation of In-lab Pleural Fluid Glucose Measurements With a Finger Stick Glucometer and Portable Point of Care Testing Device (i-STAT).
Pleural fluid glucose levels measured with bed-side point of care methods such as finger stick glucometers and I-STAT device correlate with the traditional in-lab testing methods.
Study Overview
Status
Completed
Conditions
Detailed Description
This is a prospective study which will identify patients in VAMC with a diagnosis of pleural effusion and undergoing diagnostic thoracentesis.The investigators plan to analyze the two bedside point-of-care fluid glucose testing methods (I- STAT device and finger stick glucometer) to measure pleural fluid glucose levels.
The results obtained from these two methods will be compared to the traditionally in lab measured pleural fluid glucose levels.
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- VAMC OKC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Pleural effusions
Description
Inclusion Criteria:
- any patient 18 to 99 year old with a diagnosis of pleural effusion and undergoing a diagnostic thoracentesis.
Exclusion Criteria:
- Inability to provide informed consent by the patient or the surrogate to enroll for the planned study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
iSTAT Study Group
Measure glucose of pleural fluid via glucometer, in the laboratory, and using the iSTAT device to see if the three methods give a similar reading or not.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation of pleural fluid glucose measured with a glucometer and the I-STAT with the pleural fluid glucose level measured in the Lab
Time Frame: <1 hour
|
Primary outcome will be the inter-assay precision of the finger stick glucometer and the I-STAT device as compared to the Gold standard in lab testing of pleural glucose.This will be done using the Bland-Altman plot.
|
<1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intra assay precision of pleural fluid glucose measured with a glucometer and with an I-STAT device.
Time Frame: < 1hour
|
assessment of intra assay precision of of 2 measurements of pleural fluid glucose done by the glucometer as well as the ISTAT device .
|
< 1hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Houssein Youness, MD, OUHSC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2014
Primary Completion (Actual)
August 28, 2019
Study Completion (Actual)
August 28, 2019
Study Registration Dates
First Submitted
July 31, 2014
First Submitted That Met QC Criteria
August 1, 2014
First Posted (Estimate)
August 5, 2014
Study Record Updates
Last Update Posted (Actual)
March 6, 2020
Last Update Submitted That Met QC Criteria
March 4, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3785
- VAMC OKC (Other Identifier: VAMC OKC)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Deidentified data may only be shared upon review of OUHSC Legal office and IRB.
Data sharing agreement required.
Contact research@ouhsc.edu
to initiate data requests.
No personally identifiable data will be shared.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pleural Effusions
-
Maimonides Medical CenterCompletedChest Tube Drainage of Transudative Pleural Effusions Hastens Liberation From Mechanical VentilationLiberation From Mechanical VentilationUnited States
-
Postgraduate Institute of Medical Education and...UnknownPrimary Spontaneous Pneumothorax | Malignant Pleural Effusions | Recurrent Pleural Effusions | Secondary Spontaneous PneumothoraxIndia
-
University of CalgaryCompletedPleural Effusions Post Coronary Artery Bypass GraftCanada
-
Johns Hopkins UniversityEnrolling by invitationMalignant Pleural EffusionsUnited States
-
Singapore General HospitalCompletedMalignant Pleural EffusionsSingapore
-
CareFusionCompletedMalignant Pleural EffusionsUnited Kingdom
-
Attikon HospitalCompletedPleural Diseases | Pleural Effusion, Malignant | Pleural Effusions, ChronicGreece
-
National Cancer Institute (NCI)WithdrawnMalignant Pleural Mesotheliomas (Mpm) | Malignant Pleural Effusions (Mpe) | Epithelial Tumors, Malignant | Pleural Effusions, Malignant | Mesothelin (Msln)United States
-
M.D. Anderson Cancer CenterTerminatedAdvanced Cancers | Malignant Pleural EffusionsUnited States
-
Clover Biopharmaceuticals AUS Pty LtdCompletedMalignant Pleural EffusionsAustralia